Institutional investors purchased a net $1.1 million shares of NVS during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 8.73% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EDGE ADVISORS LLC Bought 4.2 Thousand shares of Novartis
ARK INVESTMENT MANAGEMENT LLC Bought 329.00 shares of Novartis
HIGHMARK CAPITAL MANAGEMENT, INC... Sold 78.00 shares of Novartis